Bioinformatics & Data Science CROs in United States
8 published
8 published CROs match Bioinformatics & Data Science in United States.
Locations in this set include United States, China, India, United Kingdom, Europe, and Germany.
Capabilities that show up most often in this set: Small Molecule, Antibody-Drug Conjugate (ADC), Biologics (Monoclonal Antibodies), Biologics (Other), and Cell Therapy.
Matching companies
AXOlabsIntegrated CRO and CDMO specializing in nucleic acid therapeutics (ASOs, siRNA, sgRNA, aptamers) from lead identification through GMP manufacturing, with dual-site facilities in Petaluma, USA and Berlin, Germany.
Champions OncologyLeading oncology CRO specializing in preclinical and clinical specialty testing, with over 1,400 patient-derived xenograft models, comprehensive multi-omic datasets, and proprietary platforms including flow cytometry, NGS, proteomics, and histopathology services.
Crown BiosciencePreclinical oncology CRO offering 2,500+ PDX models, organoid and cell line databases, and translational platforms with biomarker discovery and AI-driven systems biology for drug development.
HitGen Inc.HitGen Inc. provides drug discovery services built on DNA-encoded library (DEL), fragment-based (FBDD/SBDD) and computational platforms for pharmaceutical and biotech clients. The company also offers oligonucleotide CDMO services and reports serving more than 600 clients globally.
Komodo HealthKomodo Health provides healthcare AI and real-world data analytics for life sciences organizations. Its platform combines a large-scale US healthcare data foundation with validated AI analyses and connected workflows for development through launch.
PharmaronPremier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.
SeqMaticSeqMatic is a CLIA-certified, CAP-accredited CRO specializing in NGS and multi-omics services. Founded in 2012 by former Illumina scientists, the company provides end-to-end sequencing workflows from discovery through clinical translation, with all work performed in its US-based Fremont laboratory.
Syngene InternationalInnovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.
Markdown mirror: /services/bioinformatics/us.md